- Home
- TLSA vs EDAP Comparison
TLSA vs EDAP Comparison
Compare TLSA & EDAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSA
- EDAP
- Stock Information
- Founded
- TLSA 2013
- EDAP 1979
- Country
- TLSA United Kingdom
- EDAP France
- Employees
- TLSA N/A
- EDAP N/A
- Industry
- TLSA Biotechnology: Pharmaceutical Preparations
- EDAP Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- TLSA Health Care
- EDAP Health Care
- Exchange
- TLSA Nasdaq
- EDAP Nasdaq
- Market Cap
- TLSA 187.0M
- EDAP 53.8M
- IPO Year
- TLSA 2000
- EDAP 1997
- Fundamental
- Price
- TLSA $1.45
- EDAP $1.51
- Analyst Decision
- TLSA
- EDAP Buy
- Analyst Count
- TLSA 0
- EDAP 3
- Target Price
- TLSA N/A
- EDAP $8.50
- AVG Volume (30 Days)
- TLSA 246.7K
- EDAP 36.8K
- Earning Date
- TLSA 07-22-2025
- EDAP 08-27-2025
- Dividend Yield
- TLSA N/A
- EDAP N/A
- EPS Growth
- TLSA N/A
- EDAP N/A
- EPS
- TLSA N/A
- EDAP N/A
- Revenue
- TLSA N/A
- EDAP $67,840,467.00
- Revenue This Year
- TLSA N/A
- EDAP N/A
- Revenue Next Year
- TLSA N/A
- EDAP N/A
- P/E Ratio
- TLSA N/A
- EDAP N/A
- Revenue Growth
- TLSA N/A
- EDAP 3.69
- 52 Week Low
- TLSA $0.63
- EDAP $1.26
- 52 Week High
- TLSA $1.91
- EDAP $5.27
- Technical
- Relative Strength Index (RSI)
- TLSA 48.43
- EDAP 34.23
- Support Level
- TLSA $1.43
- EDAP $1.51
- Resistance Level
- TLSA $1.81
- EDAP $1.63
- Average True Range (ATR)
- TLSA 0.09
- EDAP 0.10
- MACD
- TLSA -0.02
- EDAP -0.01
- Stochastic Oscillator
- TLSA 18.53
- EDAP 3.33
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.
About EDAP EDAP TMS S.A.
Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its globalized activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.